Anti-prothrombin antibodies combined with lupus anti-coagulant activity is an essential risk factor for venous thromboembolism in patients with systemic lupus erythematosus (Q74502732)
Jump to navigation
Jump to search
scientific article published on 01 September 2001
Language | Label | Description | Also known as |
---|---|---|---|
English | Anti-prothrombin antibodies combined with lupus anti-coagulant activity is an essential risk factor for venous thromboembolism in patients with systemic lupus erythematosus |
scientific article published on 01 September 2001 |
Statements
Anti-prothrombin antibodies combined with lupus anti-coagulant activity is an essential risk factor for venous thromboembolism in patients with systemic lupus erythematosus (English)
J Nojima
H Kuratsune
E Suehisa
Y Futsukaichi
H Yamanishi
T Machii
T Kitani
Y Iwatani
1 September 2001